Edward M. Messing

Edward M. Messing, M.D., is a Professor in the Department of Urology at the University of Rochester Medical Center's School of Medicine and Dentistry. An internationally renowned expert in urologic oncology, he specializes in treating bladder, kidney, prostate, and testicular cancers. His clinical approach emphasizes patient education and individualized treatment plans. Dr. Messing leads extensive research in molecular biology, cancer prevention, and clinical trials, including landmark studies on intravesical therapies and androgen deprivation timing.

His research integrates molecular biology, clinical trials, and population studies. Key interests include:

• Molecular mechanisms of bladder/prostate cancer progression
• Chemoprevention strategies (e.g., DFMO trials)
• Gender disparities in bladder cancer outcomes
• Novel diagnostics (molecular markers, imaging)
• Optimizing intravesical and systemic therapies

Publications focus on urologic oncology innovations, with recent work in radiotherapy toxicity mitigation, biomarker validation, and surgical outcomes prediction.

Awards & Honors include:

• SUO Distinguished Service Award (2020)
• Ramon Guiteras Award (2018)
• Robert S. Davis Teaching Award (2018)
• SUO Medal (2016)
• 20+ additional scientific recognitions

He holds patents for intraoperative imaging of bladder/renal tumors and contributes to national guidelines on hematuria evaluation and bladder cancer management.